Cataract Surgery

Real-world experience with dexamethasone intraocular suspension in cataract surgery

Mitchell A. Jackson, MD, presents details of a retrospective review of dexamethasone intraocular suspension 9%, including reduced postoperative inflammation.

Micro-bypass stent implant during cataract surgery: lower IOP, fewer medications

Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.

Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery

Cathleen McCabe, MD, presents results of a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.